RNS Number : 8111C
Integumen PLC
20 June 2019
 

AIM share code: SKIN

 

7:01 am 20 June 2019

 

Integumen PLC

 

("Integumen" or "Company")

 

 

Integumen strengthens senior sales and IT executive team

 

Labskin AI opens digital hub in Ireland to accommodate expansion plan across the EU and US

 

 

Integumen announces the appointment of Paul Ryan as Head of Enterprise Sales at Labskin AI. Paul has managed strategic partnering programmes and initiatives with companies such as Siemens, Microsoft, Accenture and IBM and joins the Company from 8 West Consulting, a company with more than 240 personnel, where he was Head of New Business Development. He has worked with a network of clients that include Avon, Image Skincare, Estee Lauder and Anthem Inc., a Fortune 50 US health insurer. 

 

The Company also announces the appointment of Colin O'Sullivan as Chief Information Officer (CIO). Colin is a 20-year veteran and joins the team from the Australian Medical Association where he was Group Information Officer. He brings extensive cross-platform software experience in medical and science applications ranging from enterprise applications, cloud computing, artificial intelligence, IT operations, customer experience and development operations. Over a six-year period Colin was responsible for transforming the online business of the Australian Medical Association.

 

Labskin AI Digital Hub Ireland

 

Following the RinoCloud acquisition and integration of data management and analytic services into Labskin AI, Integumen has taken new offices in Cork, Ireland to centralise global IT operations for the Group. These state-of-the-art facilities will manage IT and further AI development, incorporating Labskin AI, the virtual laboratory-as-a-service that complements the Labskin laboratory services in York, UK and provides online customer support to clients around the world.

 

Gerard Brandon CEO of Integumen commented:

 

"We are delighted and fortunate to add these two exceptional individuals to the Integumen team. Under Paul's guidance, the sales team will advance the growth of Labskin AI by leveraging the existing sales, marketing and distribution channels of the Labskin laboratory services. Colin's Australian continent AI and IT operational expertise ensures Labskin AI has an architect capable of building out continent-wide bases to deliver a robust global infrastructure.

 

Our new offices in Cork, Ireland, bring the core digital and enterprise sales teams together and are located close to many US and EU pharmaceutical corporations that fit our client target profiles. This expansion adds another exciting new chapter for Integumen."

 

Contacts

 

Integumen plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 643

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker

+44 (0) 20 3621 4120

 

About Integumen:

 

Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

 

The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSFFFIUFUSEIM